Roy Rosin is a product and innovation leader with three decades of experience building, scaling, and implementing technology that drives real-world behavior change. He currently serves as a Board Partner at First Round Capital, where he works closely with early-stage healthcare founders on product strategy, experimentation, go-to-market execution, and organizational growth.

Prior to First Round, Roy spent 12 years as Chief Innovation Officer at Penn Medicine, where he led the health system’s innovation efforts across care delivery. During his tenure, Roy’s team designed, tested, and implemented more than 150 technology-enabled interventions that reduced readmissions, ER utilization, length of stay, and clinician burden, while improving patient engagement, adherence, and quality of life.

Earlier in his career, Roy spent 18 years at Intuit, where he built and led the company’s innovation program. Starting as the product manager of Quicken, he helped grow it into the top-selling consumer software application with 14 million users. He later helped shape Intuit’s entrepreneurial and experimentation practices, contributing to long-term growth and outsized shareholder returns.

Roy received his MBA from Stanford Graduate School of Business and graduated with honors from Harvard College as a John Harvard Scholar.

Ilana Borkenstein is the cofounder and CEO of M7 Health, a company reimagining how health systems manage and support their nursing workforce. A registered nurse turned entrepreneur, Ilana began her career at Deloitte, where she led change management efforts for academic medical centers as part of the Human Capital Consulting practice. She later worked as an inpatient bone marrow transplant nurse at Memorial Sloan Kettering Cancer Center on a unit called M7, which inspired the company’s name. Ilana earned her nursing degree from the University of Pennsylvania and her MBA from Harvard Business School, where she co-founded M7 Health and was named a Blavatnik Fellow.